Best Startup
At Best Startup US we track over 1,000,000 US startups and over 3 million people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top New York based Founder operating in the Medical space. If you think a Founder is missing from this list, feel free to contact our editor on editor@beststartup.us.
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
Adam Karp
Co-Founder & CEO of Lively
Prior to Lively, Adam was the Chief Marketing Officer of 1stdibs – the world’s premier destination for unique, luxury design. At 1stdibs, Adam was instrumental in increasing the company’s revenue almost 10x; recruited and led a team of 100 and had full P&L responsibility for 1stdibs’ B2B business. Before 1stdibs Adam worked in senior roles at leading brands such as FreshDirect, Barnes & Noble and Century 21 real estate. At Century 21 he was responsible for developing and launching Century 21’s first website which at the time became the most recognized real estate website in the country and currently generates almost 50 million visits a year. After Century 21, Adam spent almost a decade at Barnes & Noble in increasingly senior roles ultimately becoming VP of Direct Marketing for both the retail stores and online. At Barnes & Noble, Adam managed some of the largest digital marketing programs in the industry, overseeing a budget of $100M. Adam graduated from the The Wharton School at the University of Pennsylvania with a degree in Economics.
Follow Adam Karp:
About Lively: Lively’s mission is to democratize, simplify and de-stigmatize the adoption and use of technically advanced hearing aids.
Elad Kolet
Co-Founder & CTO of Lively
Elad is a technology leader with more than 15 years of experience in software engineering. Most recently Elad ran the North America Solutions Engineering team at Facebook where he managed a team of 32 full-stack engineers responsible for building Facebook’s advertising products. Prior to working at Facebook, Elad worked as an Engineering Lead at Microsoft, driving the development of Windows Azure. Before Microsoft, Elad was a Senior Software Engineer at RiT technologies LTD., where he designed and built network products used by large corporate clients including Goldman Sachs UK and Morgan Stanley UK. Elad was raised in Israel and spent four years as a software engineer in the Israeli Intelligence Corps’ Unit 8200, an incubator of tech talent whose alumni have gone on to found numerous technology companies. Elad earned his BS in Computer Science from the Academic College of Tel-Aviv, Yaffo.
Follow Elad Kolet:
About Lively: Lively’s mission is to democratize, simplify and de-stigmatize the adoption and use of technically advanced hearing aids.
David Rust
Co-Founder & Advisor of Lively
David is a seasoned operator who helped scale Lyft from 25 to 1,600 employees and an $11B+ valuation. He launched Lyft’s first markets across the US and translated these learnings into the company’s national expansion playbook. David then went on to build and lead Lyft’s internal strategy team, reporting to Lyft’s COO. This team was responsible for leading high-priority strategic initiatives, from Lyft’s partnership with General Motors to its first self-driving car implementations. Prior to Lyft, David led market expansion and local marketing for one of the early pioneers in the car sharing industry, Wheelz, which was acquired by RelayRides (not Turo). David graduated from Stanford University with a degree in Environmental Engineering and was named as a member of the Forbes 30 Under 30 class of 2017.
Follow David Rust:
About Lively: Lively’s mission is to democratize, simplify and de-stigmatize the adoption and use of technically advanced hearing aids.
Esther Dyson
Founder of Way to Wellville
Follow Esther Dyson:
About 23andMe, Commercial Spaceflight Federation, EDventure Holdings, GridPoint, HICCup, New York Angels, Way to Wellville, Wellgood: 10-year nonprofit project to show impact of investing in health (vs. renting it)
Christopher Morris
Founder & CEO of Daybreak Health
Christopher is an Internal Medicine and HIV specialist at NYU Langone Medical Center focused on digital health innovations as means to transform health care quality and access. He is most interested in using emerging telehealth technologies to transform the primary care experience.
Follow Christopher Morris:
About Daybreak Health, NYU Langone Health, NYU Langone Medical Center: Daybreak Health is a digital health platform that facilitates mobile care solutions.
Bridget Osetinsky
Founder & CEO of Hyperfine
Bridget is the Founder and Chief Executive Officer of Hyperfine. She earned her Juris Doctor from Temple University James E. Beasley School of Law in 2011 and her Bachelor of Science in Physics from the University of Notre Dame in 2007.
Follow Bridget Osetinsky:
About Hyperfine: Advanced Analytics For Precision Medicine
John Fontein
Co-Founder of Sesame
John Fontein is Co-Founder and President at Sesame. Previously, he was the VP of Business Development at GoEuro where he oversaw all revenue functions including sales, marketing and partnerships. John began his career at Goldman Sachs where he worked in both the Investment Banking and Investment Management Divisions of the firm. John is a multi-platinum song-writer, producer, and sound designer. He is the recipient of numerous awards including an MTV Video Music Award, a Berklee Jazz Festival Award and a FringeNYC Award. John attended Saint Ann’s School in Brooklyn and graduated summa cum laude from Princeton University with a B.A. in Music and a certificate in Computer Science.
Follow John Fontein:
About Sesame: Sesame is a healthcare superstore, with over 10,000 medical practices offering affordable prices for care in-person or online.
David Goldhill
Co-Founder & CEO of Sesame
David Goldhill is the founder and CEO of Sesame.
Follow David Goldhill:
About Game Show Network, Sesame: Sesame is a healthcare superstore, with over 10,000 medical practices offering affordable prices for care in-person or online.
Jonathan M. Rothberg
Co-Founder, Product Architect & CEO of Butterfly Network
Jonathan Rothberg is Co-Founder, Product Architect & CEO at Butterfly Network.
Follow Jonathan M. Rothberg:
About Butterfly Network: Butterfly Network designs a medical imaging device that reduces the cost of real-time and three-dimensional imaging and treatment.
Seth Harrison
Founder & Managing Partner of Apple Tree Partners
Seth Harrison is the managing partner of Apple Tree Partners and serves as Executive Chairman of Braeburn Pharmaceuticals. He has invested in life sciences since 1991. Seth has served as founding investor, acting CEO or chairman of numerous portfolio companies. He is currently also Chairman of Tokai Pharmaceuticals, Chairman of Aileron Therapeutics and Deputy Chairman of Heartware International, all companies he founded. Prior to founding ATP, Seth was a general partner at Oak Investment Partners and earlier was a venture partner at Sevin Rosen Funds. His prior investments include: ArQule, Coelacanth, Cyrano Sciences, Gloucester Pharmaceuticals, Informed Access, SGX Pharmaceuticals, Ultracision and ViroPharma. Seth received an A.B. from Princeton University, an MD and MBA both from Columbia University and completed a surgery internship at the Presbyterian Hospital in the City of New York. From 2002 – 2010 he served on the board of the International Partnership for Microbicides, a Rockefeller Foundation/Gates Foundation sponsored public-private partnership engaged in the development of anti-HIV microbicides.
Follow Seth Harrison:
About Apple Tree Partners: Apple Tree Partners is a venture capital firm that invests in pharmaceuticals, biotech, medtech, and healthcare services.
Martin Shkreli
Founder & Executive Chairman of Turing Pharmaceuticals
Martin Shkreli is the founder and CEO of Turing Pharmaceuticals. He is the founder of Retrophin, LLC (the predecessor of Retrophin, Inc.) and former President of Retrophin, Inc. since its formation. Martin Shkreli is also the founder and managing partner of MSMB Capital Management, a New York hedge fund firm founded in 2006 that manages a variety of partnerships. Prior to MSMB, Martin Shkreli was employed at Intrepid Capital Management from 2004 to 2006 and previously at Cramer Berkowitz & Co, both of which are hedge fund firms based in New York. Martin Shkreli is an experienced biotechnology and pharmaceutical industry investor, particularly in businesses with orphan drugs. Martin Shkreli received his BBA from Baruch College.
Follow Martin Shkreli:
About Shkreli Foundation, Turing Pharmaceuticals: Turing Pharmaceuticals is a biopharmaceutical company focusing on patients with unmet medical needs.
David Ronick
Co-Founder and CEO of Minded
David is a co-founder of Minded and Stash, an LP in The Fund, and mentor to entrepreneurs at TechStars, Harvard Business School and Brown University
Follow David Ronick:
About Minded: Minded is a consumer telehealth company that makes getting mental health medication easy and affordable
Rhodemann Li
Founder, EVP Strategy & Finance of Vesselon
Mr. Li is the founder of Vesselon and is a serial medical device entrepreneur and brings more than thirty years of experience in finance, business development, strategy, patents and regulatory submissions. Prior to founding Vesselon in 2012, Mr. Li worked in private equity evaluating investment opportunities. Mr. Li co-founded an orthopedic implant company, Li Medical Technologies, which developed and sold sports medicine surgery and spinal implants. Li Medical was venture capital funded and ultimately acquired by ConMed Corporation. Mr. Li has five issued patents for medical devices. Mr. Li also worked for FMR Group, an investment vehicle for healthcare investors, and Golden Pond Healthcare, a special purpose acquisition corporation formed to assume a healthcare company, where he sourced investment opportunities. Prior to his healthcare experience, Mr. Li was a Vice President in Corporate Finance at UBS Securities and a Vice President in Corporate Lending at Manufacturers Hanover. Mr. Li holds a B.A. from Middlebury College and an M.B.A. from the University of Chicago.
Follow Rhodemann Li:
About Accelerator for Biosciences in Connect, Vesselon: Vesselon is a medical device company developing novel therapeutic Immuno-Oncology complexes.
Clay Larsen
President and CEO, Co-Founder of Vesselon
Mr. Larsen co-founded Vesselon in 2012 and brings over thirty years of executive management, marketing, sales, clinical innovation and engineering/project management in the healthcare industry. Mr. Larsen was a senior executive with FUJIFILM Medical Systems, where he was largely responsible for building the company’s first healthcare software division from the ground up. Mr. Larsen recruited the original senior architects and was instrumental in the development, marketing, commercial release and field support of Fuji’s Synapse® Picture Archive and Communication System (PACS). In a move to Silicon Valley in 1988, Mr. Larsen served in several senior roles at Acuson Corporation culminating as Vice President of New Market Development. Acuson was one of the leading ultrasound technology companies that was later acquired by Siemens. Early in his career he specialized in Sales and Marketing Management of Ultrasound and Nuclear Medicine for Picker International. Mr. Larsen holds a B.S. in Molecular Biophysics and Biochemistry from Yale University.
Follow Clay Larsen:
About Vesselon: Vesselon is a medical device company developing novel therapeutic Immuno-Oncology complexes.
Florent Peyre
Co-Founder & President of Small Door
Follow Florent Peyre:
About Small Door: Small Door provides veterinary services that are elevated, customer-centric, and hospitality-infused.
Josh Guttman
Co-Founder and CEO of Small Door
Prior to co-founding Small Door, Josh led a successful with diverse experiences that included management roles at a number of significant technology companies and roles in both investment banking and venture capital. From 2013 – 2017, Josh worked as a Partner on the early stage investing team at Softbank Capital, a $500 million venture capital arm of Softbank Corporation. While at Softbank, Josh led early stage investments in software businesses with a focus on healthcare and real estate. Before Softbank, Josh served as Senior Vice President at Outbrain, the leading content marketing platform, where he oversaw growth of the business from 50 to 250 worldwide employees in a three-year timespan. Previously, in 2007, Josh joined the early team at Sphere and helped grow the business to their eventual acquisition by Aol in 2008. Post-acquisition, Josh led the business as CEO for two years, ultimately initiating its divestiture and sale to Outbrain in early 2011. Josh began his career in investment banking at Robertson Stephens & Co in San Francisco where he participated on more than $400 million of private equity and debt financings from 1998 – 2002. Josh earned an AB from Duke University and an MBA from Columbia University. He lives in Brooklyn with his wife, two daughters, and boxer, Morrison.
Follow Josh Guttman:
About Small Door: Small Door provides veterinary services that are elevated, customer-centric, and hospitality-infused.
Jeff Dachis
Founder, Chairman & CEO of OneDrop
Follow Jeff Dachis:
About OneDrop: One Drop is a diabetes management platform that helps people navigate diabetes together.
Ashok Subramanian
Founder/CEO of Centivo
Ashok is a successful founder and CEO with significant expertise in HR and healthcare technology businesses. He is co-founder and CEO of Liazon, the nation’s leading private benefits exchange for active employees. In 2013, Liazon was acquired by Towers Watson. Ashok continues to serve as CEO of Liazon, as well as the Head of Willis Towers Watson’s Group Exchange business. Prior to Liazon, he worked as a strategy consultant at McKinsey & Company. Ashok is often sought out for his expert commentary on private and public exchanges, their role in the new healthcare landscape and their effect on businesses. He received his undergraduate degree from Princeton University, a Masters degree from Stanford University, and an MBA from the Stanford Graduate School of Business.
Follow Ashok Subramanian:
About Centivo: Centivo offers a digital health plan aimed at self-funded employers looking to provide employees with quality care they can afford.
Alan Cohen
Chief Product Officer & Co-Founder of Centivo
Alan Cohen is the Chief Product Officer & Co-Founder at Centivo. He leads the development of Liazon’s award-winning Bright Choices® Exchange and has forged numerous partnerships with national and regional benefits providers. He knows the insurance and health care industry inside and out and is often called upon by the media for his expertise. Alan was the CEO and Co-Founder of Online Benefits, a benefits management and communication technology firm. He sold Online Benefits to A.D.A.M., and then served as President of that company. He also worked in the insurance industry for Prudential, Mass Mutual and CIGNA, and managed an insurance brokerage. Alan is a graduate of Cornell University, and earned MBAs from the Columbia Business School and the London Business School, where he won the Award for Academic Excellence.
Follow Alan Cohen:
About Centivo: Centivo offers a digital health plan aimed at self-funded employers looking to provide employees with quality care they can afford.
Harry Ritter
Founder and CEO of Alma
Harry Ritter is the Founder of Alma Health.
Follow Harry Ritter:
About Alma: Alma is a membership-based network for mental health care providers.
Andrew Grover
Co-Founder and Chief Development Officer of Tend
Andy Grover is Head of Development at Tend, the dental brand bringing a hospitality mindset to oral health. With vast experience in real estate, healthcare and branding, Andy has established himself as a leader in building spaces tailored specifically to guests’ needs and emotions. At Tend, Andy spearheads every aspect of development, focusing on finding the right locations to create a holistic environment that supports guests, marrying hospitality and the sensibility of the healthcare industry. Prior to Tend, Andy was the VP of Real Estate and Development at One Medical Group. In this role, he worked with clinicians and technology specialists to develop the practice’s signature design, helping scale the industry-leading healthcare model into the business it is today.
Follow Andrew Grover:
About Tend: Tend is a technology-driven dental startup that provides hassle-free, personalized, and straightforward dental services.
Michael Stenclik
Co-Founder of Tend
Michael Stenclik is co-Founder and Chief of Staff at Tend, the dental brand bringing a hospitality mindset to oral health. Michael’s eye for innovation and expertise in bridging gaps within disjointed systems played a key role in the early stages of Tend’s development. In his current role as Chief of Staff, Michael oversees operations across finance, regulation, talent and product, in addition to driving various strategic projects internally. Previously, Michael held a product management role at Quartet Health, a behavioral health technology company. In this role Michael helped develop an innovative product that delivered improved outcomes while lowering the total cost of care, creating a better experience for both guest and provider. Prior to this, Michael served as an engagement manager for Farenheit 212, consulting for several Fortune 500 companies.
Follow Michael Stenclik:
About Tend: Tend is a technology-driven dental startup that provides hassle-free, personalized, and straightforward dental services.
Samir Housri
CEO & Co-Founder of The Mednet
Samir Housri the CEO & Co-founder of theMednet. Under his leadership theMednet has become the largest online physician network in Oncology and one of the fastest growing in medicine. Samir’s career spans nearly 20 years in digital media that spans operations, technology and strategy. Most recently he was part of the investment team at Rho Ventures where he sat on multiple boards and deployed over $50M in capital. Prior to that, he was part of EMI Music’s global business development team where he drove the launch of EMI’s ad-supported video platform. He was also involved in all aspects of digital content licensing and distribution, including contract negotiations, technical implementation and monetization. Prior to EMI, Samir served as a management consultant with Bain & Company where he worked on strategy for technology and media clients. He started his career as a software engineer for Major League Baseball and was a key member of the team that built MLB.com.
Follow Samir Housri:
About The Mednet: The Mednet is a physician-only community for expert answers to real world clinical questions in oncology.
Nadine Housri
Co Founder & Chief Medical Officer of The Mednet
Follow Nadine Housri:
About The Mednet, Yale University School of Medicine: The Mednet is a physician-only community for expert answers to real world clinical questions in oncology.
Nick Ganju
Co-Founder of Zocdoc
Nick Ganju is a founder at ZocDoc and leads strategic initiatives that address some of the company’s most impactful opportunities. He helped build ZocDoc because he believes that the power of technology can bring about a more efficient healthcare system. He has extensive experience in product development, database management and site architecture, including having personally built the earliest iterations of ZocDoc and directly overseeing its development for many of its first years Prior to ZocDoc, Nick worked as the CTO of cfX, where he oversaw the design and implementation of financial software used by several Fortune 100 Wall Street firms. A Trilogy Development Alumnus, Nick previously lived in Silicon Valley. There, he played a pivotal role in the architecture and development of eBoodle (later acquired by BizRate), and in 2002 founded his first company, called Mixonic. He remained at Mixonic as the architect, manager, and lead programmer until moving to New York. Nick was awarded an MBA from Columbia Business School in 2008. He also has a bachelor’s degree in Computer Science from the University of Illinois at Urbana-Champaign. He first met ZocDoc founder and CEO Cyrus Massoumi when the two shared a desk at Trilogy Software. Nick was born and raised in Chicago, and currently resides in New York. When he’s not working, the former Bay Area Amateur Billiards Champion can be found fronting his semi-professional cover band.
Follow Nick Ganju:
About Zocdoc: Zocdoc is a digital marketplace company that connects healthcare patients and doctors.
Oliver Kharraz
CEO & Co-Founder of Zocdoc
Oliver Kharraz, MD, is CEO and founder of Zocdoc. Oliver is the most recent doctor in a 300-year family tradition. Over the course of his wide-ranging career, Oliver has accrued comprehensive experience effecting change and building efficiency in large scale healthcare organizations using information technology. Prior to Zocdoc, Oliver was an Associate Principal at the global management consulting firm McKinsey & Company. During his seven-year tenure at McKinsey & Co., Oliver developed and implemented new patient utilization models for the national health services of a number of governments and major hospital chains. In 1994, Oliver built and sold his first business – a forerunner of early internet software. He later became a resident doctor at the clinic of Ludwig Maximilian University in Munich, where he earned an MD and a Doctorate in Neuroscience. Oliver also has a Masters Degree in Philosophy from the Jesuit College of Philosophy in Munich. He is also a member of the Council on Foreign Relations. Born in Germany, Oliver immigrated to the U.S. during his work for McKinsey & Co. He currently resides in Brooklyn, NY, with his wife and their twin daughters.
Follow Oliver Kharraz:
About Creative Destruction Lab (CDL), Zocdoc: Zocdoc is a digital marketplace company that connects healthcare patients and doctors.
Robin Berzin
Founder & CEO of Parsley Health
Robin Berzin, MD is the founder and CEO of Parsley Health, a primary care medicine provider with a data-driven, whole body approach. A summa cum laude graduate of the University of Pennsylvania, she completed medical school at Columbia University’s College of Physicians and Surgeons and trained in internal medicine at Mount Sinai Hospital in New York City. Dr. Berzin also trained with the Institute for Functional Medicine, where she acts as an advisor on digital technology. She speaks regularly for organizations including Stanford Medicine X, Health 2.0, Rock Health, Summit Series, and Further Future about how health care can be reinvented.
Follow Robin Berzin:
About Parsley Health: Parsley Health is redesigning primary care by integrating the latest in medical testing, technology and nutrition research.
Matthew Putman
Co-Founder & Chief Executive Officer of Nanotronics Imaging
Matthew Putman Co-Founded Nanotronics Imaging, LLC in 2008 and serves as its Chief Executive Officer. Matthew Putman is a Professor and Researcher at Columbia University. He was an owner and Vice President of Development for Tech Pro, Inc., which was acquired by Roper Industries in March 2008. During his time at Tech Pro, he lead two acquisitions, and the transformation of the instrument manufacturer into new global markets, having formed partnerships or subsidiaries in 15 nations. He serves as a Director of Nanotronics Imaging, LLC. He has lectured at The University of Paris, USC, University of Michigan, and The Technical University of Sao Paulo. He has also produced several plays and films, and is an accomplished composer. He is a founding member of the World Science Festival. He is on the Executive Board of the Montauk Observatory, and is an Artist in Residence for Imagine Science Films. He holds 5 patents, and has published over 20 technical papers, and in 2002 he won the ACS Best Paper Award. He has a Ph.D. in Applied Physics.
Follow Matthew Putman:
About Nanotronics Imaging, The Thiel Foundation: Nanotronics Imaging is a microscopy and software company delivering rapid testing and analysis solutions.
Thomas Oxley
CEO & Founder of Synchron
Thomas Oxley is the CEO at Synchron
Follow Thomas Oxley:
About Defence Science and Technology, Florey Institute of Neuroscience & Mental Health, Mount Sinai Health System, Synchron, Synchron, University of Melbourne, VascuLab: Synchron is a bioelectronics medicine company that develops neuromodulation solutions for previously-untreatable nervous system conditions.
Evan Roberts
Founder & COO of Phreesia
As VP of Customer Solutions and co-founder of Phreesia, Inc., Evan is the technical visionary responsible for driving Phreesia’s initiative to pioneer patient self-service registration and educational solutions, at a low cost to clinicians in their medical practices. Prior to founding Phreesia, Evan was a Senior Sales Engineer at Spotfire, a leading provider of interactive analytics software, where he helped to penetrate new markets including pharmaceutical sales and marketing, resulting in significant net new revenue. In that capacity he developed innovative applications, and trained and managed his team to support and nurture these new markets. He began his career at Spotfire as a member of the Professional Services team. Evan holds a degree in Computer Engineering from Tufts University.
Follow Evan Roberts:
About Phreesia: Phreesia automates the patient check-in process by collecting personal health information on the PhreesiaPad.
Mike Simmons
CEO & Founder of andros
Follow Mike Simmons:
About andros: andros is a provider of network management solutions for healthcare organizations.
Anthony Girand
CEO, Co-Founder of VoyagerMed
Anthony has over 15 years of experience as a Private Wealth advisor on Wall Street. He left Forbes Family Trust in 2014 to start VoyagerMed and has been spearheading the company’s digital operations ever since. Contact Anthony at anthony@voyagermed.com
Follow Anthony Girand:
About VoyagerMed: A medical tourism marketplace faciliating access to life changing medical innovations from trusted doctors around the world.
Struan Coleman
Chief Medical Adviser, Co-Founder of VoyagerMed
Struan Coleman MD, PhD, is a world-renowned, board-certified orthopedic surgeon specializing in hip preservation and sports medicine at Hospital for Special Surgery in New York City and the Vincera Institute in Philadelphia. Struan Coleman earned a medical degree from Columbia College of Physicians and Surgeons and holds a D.Phil in Microbiology from Oxford University, England. He completed both his residency in Orthopedic Surgery and a fellowship in Sports Medicine at the Hospital for Special Surgery. During his fellowship, Struan Coleman worked as an assistant physician for the New York Giants football team and is currently the Head Team Physician for the New York Mets baseball team. Struan Coleman focuses on the treatment and management of sports related injuries of the hip, knee, and shoulder, with a particular interest in hip arthroscopy and hip preservation. In his practice, he treats young, athletic patients with hip pathology; in addition, he has performed arthroscopic surgery on many high level athletes with hip problems, including NFL players from the Green Bay Packers, Oakland Raiders, and Washington Red Skins. Struan Coleman also combines his clinical practice with research relating to the fields of hip arthroscopy and sports medicine, and he has published numerous articles and written chapters in those fields. Struan Coleman holds numerous patents for technologies that are utilized by sports medicine physicians and surgeons. Most recently, he patented the technology behind the CyMedica QB1 Rehabilitation System, which is used to treat quadriceps atrophy. Struan Coleman is the founder of CyMedica Orthopedics and he is on the board of the company.
Follow Struan Coleman:
About CyMedica, New York Mets, VoyagerMed: A medical tourism marketplace faciliating access to life changing medical innovations from trusted doctors around the world.
Edouard Gaussen
Chief Executive Officer and Co-Founder of Mantra Health
Edouard Gaussen is a Co-Founder and CEO at Mantra Health. Edouard has had experience operating and advising startups on growth and user acquisition. He was one of the early employees at Tinder, a social discovery app based in Los Angeles, which disrupted the online dating industry and creates millions of matches every day. His role evolved from handling all on ground growth strategies in the Canadian market to leading the international marketing team across 15 different markets worldwide. As an active member of the Montreal tech community, Edouard serves as a mentor at the Dobson Centre for Entrepreneurship at McGill University. Edouard holds a B.A. in Economics and Finance from McGill University. Born and raised in Switzerland, he is a dual French-Swiss citizen and calls Montreal home.
Follow Edouard Gaussen:
About Mantra Health: Mantra Health is a digital mental healthcare company designed for all university students.
Matt Kennedy
Co-Founder, COO of Mantra Health
Follow Matt Kennedy:
About Mantra Health: Mantra Health is a digital mental healthcare company designed for all university students.
Ryan Hungate
CEO & Founder of Simplifeye
CEO & Founder of Simplifeye.
Follow Ryan Hungate:
About Simplifeye: Simplifeye empowers doctors by automating the business of their practice
Jordan Feldman
Co-Founder & CEO of Rightway
Bachelor of Arts, Government & Economics – Harvard,Investment Banking – Goldman Sachs,Investment Professional – Redbird Capital.
Follow Jordan Feldman:
About Rightway: Rightway is a health technology company that is simplifying the healthcare experience for clients and members.
Dr. Bernard Kruger
Founder of Sollis Health
Board-certified in Oncology and Internal Medicine and on faculty at Weill Cornell, Dr. Kruger has been serving the needs of his patients for more than 30 years from his office in Manhattan’s Upper East Side. As a pioneer of concierge medicine, Dr. Kruger has devoted his career to making the doctor–patient relationship as comfortable, reliable and easy as possible.
Follow Dr. Bernard Kruger:
About Sollis Health: Sollis Health offers 24/7 concierge medical centers that handle emergencies, everyday checkups, and everything in between.
Andrew Olanow
Founder of Sollis Health
A passionate advocate for improvements in the healthcare industry, Andrew has been a healthcare investor and analyst for more than 10 years at Generation IM, Morgan Stanley and Merrill Lynch. He has consulted for many health systems and advised multinational institutions toward more effective and efficient healthcare models. Andrew holds an MBA from London Business School and a BA from Columbia University.
Follow Andrew Olanow:
About Sollis Health: Sollis Health offers 24/7 concierge medical centers that handle emergencies, everyday checkups, and everything in between.
Nayan Jain
Founder & Chief Technology Officer of Heartbeat Health
Nayan Jain is the CTO of Heartbeat, after founding two other healthcare businesses in New York, he now focuses on heart disease prevention by matching patients with the right doctor. He completed a Presidential Innovation Fellowship at the White House, where he worked on national health data initiatives and deployed one of the first sensor networks for employee wellness. As founding engineer at Rally (acquired by UnitedHealth), Nayan was responsible for the company’s core mobile and web platforms. He received his BS in Computational Media (CS and HCI) at Georgia Institute of Technology.
Follow Nayan Jain:
About Heartbeat Health, Leo Health: Heartbeat Health is a healthcare technology company that delivers virtual-first cardiovascular disease prevention and management.
Jeffrey Wessler
Founder, CEO of Heartbeat Health
Follow Jeffrey Wessler:
About Heartbeat Health: Heartbeat Health is a healthcare technology company that delivers virtual-first cardiovascular disease prevention and management.
Mark Hanson
Founder & Chief Product Officer of Heartbeat Health
Follow Mark Hanson:
About Heartbeat Health: Heartbeat Health is a healthcare technology company that delivers virtual-first cardiovascular disease prevention and management.
Stuart Hinchen
Co-Founder & CEO of QuVa Pharma
Stuart Hinchen is Founder &CEO @ QuVa Pharma. Stuart Hinchen is currently Chief Executive Officer of JHP Pharmaceuticals, LLC (“JHP”), having acted as President and Chief Operating Officer of JHP from 2007 to 2011. He has been instrumental in the establishment of JHP as a leading injectable pharmaceutical business in the USA. Previously, Stuart was President of Mayne Pharma Americas (“Americas”), a unit of Mayne with $180 million in revenue that was focused on the manufacture, development and sale of generic injectable pharmaceuticals, primarily into the hospital market. Stuart led the Americas activity through a period of significant growth through acquisition, product line extension, and product in-licensing. Having first established Mayne Pharma USA as a stand-alone business, he helped build the division into the fourth largest US generic oncology provider. Prior to his experience with Mayne Americas, Stuart was a General Manager in Mayne’s Mergers and Acquisitions Group, heading transactional and operational teams involved in the purchase, sale and integration of businesses. After joining Mayne in 1995, Stuart worked on a variety of different projects, including the restructuring and sale of the company’s Benelux logistics business to Hays PLC.
Follow Stuart Hinchen:
About QuVa Pharma: QuVa Pharma is a pharmaceutical company engaged in the innovation and production of pharmaceutical products.
Peter Jenkins
Co-Founder & Chief Development Officer of QuVa Pharma
Peter Jenkins is Co-Founder & Chief Development Officer at QuVa Pharma.
Follow Peter Jenkins:
About QuVa Pharma: QuVa Pharma is a pharmaceutical company engaged in the innovation and production of pharmaceutical products.
Dan Horbatt
CTO and Founder of Particle Health
Dan Horbatt is the CTO and Founder of Particle Health.
Follow Dan Horbatt:
About Particle Health: Particle Health is an API designed for healthcare innovators that gives access to vital medical data.
Troy Bannister
Founder and CEO of Particle Health
10+ years in healthcare as an EMT, clinical researcher and innovations specialist. Focused on disruptive models and new digital technologies. Founded a company focused on breaking down barriers that make it difficult to share data between large healthcare organizations.
Follow Troy Bannister:
About Particle Health: Particle Health is an API designed for healthcare innovators that gives access to vital medical data.
Eric Schweiger
CEO & Founder of Schweiger Dermatology
Eric Schweiger, M.D. is the founding dermatologist and C.E.O. of Schweiger Dermatology Group.
Follow Eric Schweiger:
About American Academy of Dermatology, Clear Clinic, Mount Sinai Health System, Schweiger Dermatology: Schweiger Dermatology is a full service cosmetic & general dermatology.
Chaim Welz
Founder & President of Welz
Chaim Welz is the Founder and President at Welz.
Follow Chaim Welz:
About Welz: Welz, formerly known as NY COVID TEST, is on a mission to bring instant care, COVID-19 testing and vaccinations.
Elad Walach
CEO and Co-Founder of Aidoc
Elad Walach is a co-founder and CEO of Aidoc. He is an expert in AI with visionary business insights in the healthcare space. Since establishing Aidoc in early 2016, Elad has led the company through 2 rounds of investment (total of $13Mil), driven the commercial availability of 2 product lines (detecting brain hemorrhages and C-Spine fractures), and created an install base of 16 global health systems while growing the company to over 50 employees. Elad began his career in the elite Israeli Defense Force technology program “Talpiot”. He led AI research in the Israeli Air Force where he initiated and managed several teams focused on machine learning and computer vision projects. Elad holds a B.Sc. in Mathematics and Physics from The Hebrew University of Jerusalem, and has published multiple academic papers on deep learning.
Follow Elad Walach:
About Aidoc: Aidoc specializes in developing artificial intelligence tools for radiologists and multidisciplinary response teams.
Konstantin Mehl
CEO, Founder & President of Kaia Health
Konstantin is a serial entrepreneur. His last company foodora, a global food delivery company was sold to delivery hero in 2015 after reaching 500 employees and 5,000 drivers. His current company Kaia has the mission to build the biggest platform for chronic disease management, powered by computer vision. His angel investments include more than 20 companies in the US and Europe. He holds a dual Masters from Columbia University and a Bachelors degree from Technical University Munich.
Follow Konstantin Mehl:
About Kaia Health, Kaia Health: Kaia Health is a digital therapeutics company that creates evidence-based treatments for a range of medical disorders.
Christopher Altchek
Founder & CEO of Cadence Solutions
Chris Altchek is CEO and co-founder of Mic, a leading news and media company for young people. Each month, more than 20 million readers rely on Mic’s unique sensibility to stay informed and make sense of the world. From global affairs and politics to technology and science to sports and music, Mic offers insightful stories and compelling perspectives on the issues that define a generation. Before starting Mic, Altchek worked in investment banking at Goldman Sachs. Earlier experiences include policy work for the National Economic Council at the White House, political organizing for the Service Employees International Union, and voter outreach for New York City Mayor Michael Bloomberg’s successful 2009 re-election. Altchek was named to the 2014 Forbes’s 30 Under 30 list.
Follow Christopher Altchek:
About Cadence Solutions, Lightspeed Venture Partners: Cadence Solutions is a provider of remote patient monitoring and virtual care services.
David Benshoof Klein
Founder & CEO of Click Therapeutics
David Benshoof Klein is a healthcare investor and entrepreneur with over 13 years life science industry experience; he has played key roles in founding, financing and developing more than 10 life science companies. In 2012, Mr. Klein co-founded Click Therapeutics, Inc. which focuses on engineering, validating and commercializing Digital Therapeutics™ applications to benefit people with brain disorders and neuropsychiatric dysfunction. He formerly served as Managing Director at a life science asset management firm & senior consultant to Pfizer.
Follow David Benshoof Klein:
About Click Therapeutics: Click Therapeutics delivers safe and effective digital treatments to patients in need.
Adam Hanina
Co-Founder, Board Director of AiCure
Adam Hanina is CEO and co-founder of AiCure. He has been a strategist in healthcare software delivery for over fifteen years and holds over a dozen patents in his name. Prior to AiCure, he helped further develop Cerner Corporation’s European strategy and was a Visiting Fellow of eHealth at Imperial College in London, UK. Mr. Hanina has spoken extensively on the topic of healthcare innovation and has acted as a subject-matter expert on medication adherence technologies for the National Institutes of Health (NIH). He is currently a principal investigator for multiple NIH innovation grants. He holds an MBA from the Wharton School of Business.
Follow Adam Hanina:
About AIC Innovations Group, AiCure: AiCure is an advanced data analytics company that uses artificial intelligence to understand how patients respond to treatments.
Taylor Justice
Co-Founder & President of Unite Us
Follow Taylor Justice:
About Unite Us: Unite Us provides a collaboration and coordination software, streamlining the delivery of health and social services.
Andrew Price
Co-Founder/Director of Outreach of Unite Us
Follow Andrew Price:
About Decisive Point, Unite Us: Unite Us provides a collaboration and coordination software, streamlining the delivery of health and social services.
Darren Sherman
President, Chief Operating Officer, Director and Founder of Orchestra BioMed
Darren Sherman is a Managing Partner of Orchestra. He is also Chief Technical Officer of Accelerated Technologies, Inc. (ATI) as well as Chief Executive Officer of Caliber Therapeutics, Inc., an OMV II Fund Portfolio Company. He has over 17 years of management and entrepreneurial experience in the medical technology industry spanning interventional cardiology, cardiac electrophysiology, sudden cardiac death, stroke, and neurovascular therapies. He currently serves as a director of Caliber Therapeutics and Vivasure Medical. Prior to joining Orchestra, Mr. Sherman held various positions in executive management for Cordis Neurovascular (CNV), a Johnson & Johnson company, including Executive Director R&D and Director of Strategic Marketing for stroke products. He had worldwide responsibility for all neurovascular R&D and global strategic marketing responsibilities for the Stroke franchise, including budgets, portfolio of products and strategic planning. Mr. Sherman made significant contributions to the design and commercialization of a series of key products including the Enterprise Vascular Reconstruction Device and the Orbit Embolic Coil as well as directed the filing of over 100 patents. Prior to joining CNV, Mr. Sherman played an integral role in the formation and development of Revivant Corp (acquired by Zoll) while working with Thomas J. Fogarty, MD at Fogarty Engineering. He was Revivant’s first employee and managed the design, development, and testing of the AutoPulse device from concept through market introduction. In addition to the R&D related activities, Mr. Sherman supported the clinical research, marketing, and intellectual property efforts. The AutoPulse is a lightweight, portable tool replacing the need for manual chest compressions during cardio-pulmonary resuscitation (CPR) for patients suffering from sudden cardiac arrest. Prior to Revivant, Mr. Sherman held positions in research and development for Cardiac Pathways Corp., prior to its acquisition by Boston Scientific, and Baxter Healthcare. In each of these companies, he participated in the creation, development and launch of products. Mr. Sherman has authored 45 U.S. patents with an additional 58 published applications. He earned a BS degree in Bioengineering from the University of California, San Diego.
Follow Darren Sherman:
About Orchestra BioMed, Orchestra Medical Ventures: Orchestra BioMed is a biomedical innovation company that provides high-impact solutions for large unmet needs in procedure-based medicine.
David Hochman
Chief Executive Officer and Founder of Orchestra BioMed
David Hochman is a Managing Partner of Orchestra. He has over 14 years of venture capital and investment banking experience. He is also President of Accelerated Technologies, Inc (ATI), a medical device accelerator managed by Orchestra. Prior to joining Orchestra, Mr. Hochman was Chief Executive Officer of Spencer Trask Edison Partners, LLC, a principal investment partnership focused on early stage healthcare companies. He was also Managing Director of Spencer Trask Ventures, Inc. during which time he was responsible for directing the firm’s venture banking group and led financing transactions for over 20 early-stage companies, securing over $420 million in equity capital. Mr. Hochman currently serves as a director of Caliber Therapeutics, Vital Access, BackBeat Medical, and Prescient Medical, Inc., an interventional cardiovascular device company Mr. Hochman co-founded in 2004. Mr. Hochman was an advisor and observer to the board of Health Dialog Services Corporation, a world leader in collaborative care management that was acquired in 2008 by the British United Provident Association for $750 million. He was also a co-founder and director of PROLOR Biotech, Inc., a biopharmaceutical company developing longer-lasting versions of approved therapeutic proteins, as well as a board advisor to Idera Pharmaceuticals, Inc., a world leader in Toll-Like Receptor-based therapeutics. Mr. Hochman currently serves as a director of the following nonprofit organizations: the Citizens Committee for New York City, the AIDS Action Foundation; and the Mollie Parnis Livingston Foundation. He graduated with honors from the University of Michigan.
Follow David Hochman:
About Orchestra BioMed, Orchestra Medical Ventures: Orchestra BioMed is a biomedical innovation company that provides high-impact solutions for large unmet needs in procedure-based medicine.
Dedi Gilad
CEO & CO-Founder of TytoCare
With over 18 years of leadership positions both in startups as well as global companies, Dedi brings extensive knowledge and hands-on experience in R&D, Marketing and Operations of multi-disciplinary products in the fields of Healthcare IT, Enterprise Systems, Internet and SaaS. Before founding Tyto Care, Dedi was the General Manager at MDG Medical, VP R&D at WorkplaceIQ (acquired by Siterra / Accruent) and VP R&D at Aman Group. Dedi earned an MBA and a B.Sc. in Industrial Engineering from the Tel-Aviv University.
Follow Dedi Gilad:
About TytoCare: TytoCare is a telehealth platform for AI-powered and on-demand remote medical examinations.
David M. Epstein
Founder, President & Chief Executive Officer of Black Diamond Therapeutics
David M. Epstein, PhD is founder & CEO of Black Diamond Therapeutics. David is a biopharma leader and executive who has successfully led large and small R&D teams in academic, virtual, start-up, mid-size and global large-pharma settings. His teams have progressed multiple novel agents through development in oncology, cardiovascular disease, and retinal degeneration. David was Chief Scientific Officer at Astellas/OSI Pharmaceuticals, and previously a founder of Archemix Corp. Most recently Vice Dean, Innovation & Entrepreneurship, and Associate Professor in Cancer & Stem Cell Biology at Duke-NUS Medical School, Singapore, David founded and built Duke-NUS’s Centre for Technology & Development (CTeD). The Centre has developed a pipeline of innovation projects, completing 2 product-development biopharma partnerships, and 7 spin-outs from its technologies. David’s research focuses on RNA splicing and immune-tumor cell interactions in cancer. He earned a Ph.D. in Biochemistry at Brandeis University and completed a joint post-doctoral fellowship leading a collaboration in protein structure, function and NMR dynamics between the labs of Steven Benkovic (Penn State) and Peter Wright at The Scripps Research Institute in La Jolla.
Follow David M. Epstein:
About Black Diamond Therapeutics: Black Diamond Therapeutics is a precision oncology medicine company pioneering the discovery and development of small molecule.
Gina Bartasi
Founder & Chief Executive Officer of Kindbody
A seasoned entrepreneur and thought leader, Gina brings more than 20 years of experience to the digital healthcare industry with a proven track record of building new businesses from the ground up. She has a long history of spotting and capitalizing on market trends, where she’s launched several key brands and digital media properties including Fertility Authority, a suite of sites providing financing and support for both IVF and egg freezing patients. Today, Gina is the Chief Executive Officer for Progyny – a leading digital health company. The company combines data and science to provide the first end-to-end, proactive fertility solution for employers. Our solution increases success rates and reduces time to pregnancy. Gina was an Ernst & Young Entrepreneur of the Year finalist, Metro Atlanta Chamber’s Small Business Person of the Year finalist and a finalist for Woman of the Year in Technology. She received her BS from the University of North Carolina at Chapel Hill and is a graduate of Harvard Business School. She serves on the boards of The Carter Center’s Board of Councilors, Camp Sunshine, and UNC-Chapel Hill’s Department of Communications Studies. Gina and her husband reside in New York City.
Follow Gina Bartasi:
About Kindbody: Kindbody is a health and technology company providing fertility, gynecology, and family-building care.
Joanne Schneider
Co-Founder & Head of Product of Kindbody
Joanne Schneider is a co-founder and head of product at Kindbody.
Follow Joanne Schneider:
About Kindbody: Kindbody is a health and technology company providing fertility, gynecology, and family-building care.
Alan Rigby
Co-Founder, President & Chief Executive Officer of HiberCell
Alan Rigby is a passionate and innovative oncology leader with over 20 years of academic and industry experience in the area of data driven oncology drug discovery from concept to clinical candidate to genetically enabled first-in-man studies. Dr. Rigby is committed to leveraging patient material and data for use in the identification, stratification and development of ‘next generation’ cancer therapeutics for use in responder populations. This ‘commitment’ has resulted in clinically validated large and small molecule therapeutics for several cancer indications. Most recently, Alan led a prioritized and focused effort to translate ‘Natures Intracellular Biologic’ into transformative medicines for oncology and antibiotic resistance while chief scientific officer of Warp Drive Bio., a Cambridge based biotechnology company that was recently acquired. Alan joined Warp Drive Bio following a tenure as senior vice president and chief scientific officer at Synta Pharmaceuticals. While at Synta Alan led research and development efforts for Synta’s HSP90 clinical candidate, Ganetespib, as well as restructuring the preclinical small molecule drug conjugate platform. Prior to joining Synta, Dr. Rigby was vice president, global antibody drug conjugate biology, and head of external innovation for oncology research at the New York site for Eli Lilly and Company. Before launching his biotech/ pharmaceutical career Dr. Rigby was a National Institutes of Health (NIH) funded assistant professor and principal investigator at Beth Israel Deaconess Medical Center, Harvard Medical School. While at Harvard Medical School, he founded and directed the Drug Discovery and Target Validation Program within the Beth Israel Deaconess Medical Center. As a mentor and advisor Alan continues to work with numerous organizations to assemble and chair scientific conferences with a focus on translating innovative science and oncology-centric platforms into robust and durable clinically validated strategies. Alan Rigby is on the Editorial Advisory Board for Future Medicinal Chemistry, was North American Editor for Current Computer Aided Drug Discovery and has published more than 55 scientific papers, a book chapter and has 12 patents that have published or are pending. Alan holds an Honors BSc. in Biochemistry from the University of Western Ontario in London, Ontario, Canada and a Ph.D. in Biochemistry from the same University.
Follow Alan Rigby:
About HiberCell: HiberCell is a biotechnology company developing treatments to prevent cancer relapse and metastasis.
Ari Nowacek
Co-Founder and Chief Business Officer of HiberCell
Ari Nowacek, M.D, Ph.D. is a Principal with ARCH, joining the company as an Analyst in March 2015. Dr. Nowacek focuses on identifying and evaluating new life sciences technologies and also provides operating assistance to early-stage portfolio companies. Dr. Nowacek is a physician-scientist by training with over 20 peer-reviewed publications and greater than 400 citations in the areas of neuroscience, virology, and antiretroviral therapeutic development. His research has led to 3 issued and 2 pending patents for therapeutic and R&D applications. He holds a B.S. in Biology and a B.S. in Psychology from the University of Indiana-Bloomington where he graduated Magna Cum Laude and was elected to Phi Beta Kappa. He also holds an M.D. and Ph.D. from the University of Nebraska Medical Center and an M.B.A. from the University of Nebraska-Omaha. He subsequently completed a medical residency in pathology and post-doctoral research at The University of Chicago and Massachusetts General Hospital.
Follow Ari Nowacek:
About ARCH Venture Partners, HiberCell: HiberCell is a biotechnology company developing treatments to prevent cancer relapse and metastasis.
Julio Aguirre-Ghiso
Co-Founder of HiberCell
Julio Aguirre-Ghiso is the Co-Founder at HiberCell.
Follow Julio Aguirre-Ghiso:
About HiberCell: HiberCell is a biotechnology company developing treatments to prevent cancer relapse and metastasis.
Zain Qayyum
CEO and co-Founder of Medsender
CEO @ Medsender
Follow Zain Qayyum:
About Medsender: Modernizing healthcare communication and automating care coordination workflows
Jeff De Flavio
Founder, Board Member of Groups Recover Together
Jeff De Flavio is the Founder and Board Member of Groups Recover Together.
Follow Jeff De Flavio:
About Affect Therapeutics, Groups Recover Together: Groups Recover Together provides accessible and affordable medication-assisted treatment (MAT) for opioid addiction.
Madjid Salimi
Co-CEO & Co-Founder of AMBOSS
Dr. med. Madjid Salimi is a licensed physician, software engineer and serial entrepreneur. While studying computer science and economics at the University of Cologne, he co-founded and served as managing director of Netempire AG and also co-founded TomPower GmbH und Unit Parktech AG. While retaining his seat on the advisory board of Netempire, he then went on to study Medicine at the Universities of Göttingen, Hamburg and La Sapienza in Rome where he went on to earn his doctorate in medical education. With the additional accreditation of an entrepreneurship development program at M.I.T., Cambridge, USA, Madjid was set on the path to co-founding MIAMED GmbH where he currently serves as Co-CEO and Head of Product Development. Madjid completed his clinical rotations in Surgery at the University of Buenos Aires and Radiology at Mount Sinai (New York) and UCSF (San Francisco) and also spent parts of his education in Brazil, Italy and South Africa. Madjid is also a keen lacrosse player and went on to represent the German national side for several years before also coaching the Italian national team.
Follow Madjid Salimi:
About AMBOSS: Improving healthcare by making medical knowledge universally accessible.
Partha Mitra
Founder & Chief Scientific Advisor of Clarapath
Partha Mitra is the Professor at Cold Spring Harbor Laboratory.
Follow Partha Mitra:
About Clarapath, Cold Spring Harbor Laboratory, Indian Institute of Technology Madras: We are a medical robotics company developing the SectionStar, a platform to mimic the human histotechnician.
Andreas Typaldos
Founder & CEO of Kerna Health
Andreas Typaldos has guided the emergence of Xandros from desktop Linux provider to that of a leader in netbook, messaging, digital marketplace, and cross-platform management solutions. He is a 30-year technology veteran and entrepreneur and founder of Axs-One (formerly Computron), a global software firm supplying Fortune 500 companies with financial services, financial applications, workflow, and data-management applications. Mr. Typaldos is a principal founder of a broad spectrum of companies in the internet infrastructure, broadband, SMS and mobile transactions, technology enabling, instant messaging, and compliance software spaces. He was an early investor through Linux Global Partners in Ximian, Xandros, and CodeWeavers, and is currently Chairman/Managing Member of Enikia, a state-of-the-art system-on-a-chip semiconductor company focused on delivering broadband and multi-media distribution over electrical power lines.
Follow Andreas Typaldos:
About Kerna Health, Xandros: Kerna Health is a next-generation digital health monitoring and virtual care company.
Scott Becker
Co-Founder, CBO of Delve Therapeutics
Scott Becker, Vice President of Enterprise Products, joined Schrödinger in 2012. He received his BS in Computational Biology from University of Pennsylvania. Scott is a technical entrepreneur, startup advisor, and angel investor. He was Co-Founder and CTO of Invite Media, a venture backed advertising startup that was acquired by Google in 2010.
Follow Scott Becker:
About Delve Therapeutics: Delve Therapeutics is investigating novel oncology therapeutics
Isaac Litman
Founder and CEO of Neteera
Mr. Litman founded Neteera after serving as CEO for Mobileye (NYSE: MBLY) Aftermarket for six years until the IPO. Prior to that Mr. Litman served as CEO for Telepath, Motorola´s exclusive distributor in Israel and East Europe, CEO for ABSC, focused on business intelligence and development and was also a special projects manager for the Israeli Prime Minister´s office. Mr. Litman graduated from the Tel-Aviv University Law school, holds a B.A in Economics from the Tel-Aviv University and an MBA from the Bar-Ilan University. Mr. Litman was honourably discharged from the Israeli army with rank of Major and his last active duty position was as reconnaissance company commander.
Follow Isaac Litman:
About Neteera: Neteera developed an AI-powered sensing platform to reduce treatment failures & improve outcomes in health screening, diagnosis & treatment.
David Champion
CEO and Co Founder of Maya Health
David Champion’s passion is to create new behaviors through design. In 2005 Champion founded an educational non-profit so kids in Kenya weren’t held back from school because they couldn’t afford books. At the same time, he studied Architecture at Cambridge. Graduating at the top of my class gave me the opportunity to work with Daniel Libeskind on the master-plan for Ground Zero, and to begin my life in New York. David Champion became fascinated with Psychology and built a company curating events to bring business leaders together with psych professors, discussing better ways to harness people’s minds in business. In founding DSChampion his knowledge of software development saw us produce unique user applications for a range of clients, including Zuse Inc, infoHubs, and Baker Technologies, of which he is also co-founder.
Follow David Champion:
About Maya Health: Maya Health is a software platform designed to track, measure, and provide illustration of the health outcomes of their clients.
Arjun Ganesan
Co-Founder & CEO of Ancera
Arjun Ganesan is Founder & CEO at Ancera.
Follow Arjun Ganesan:
About Ancera, Creative Destruction Lab (CDL): Ancera is a biotech company focused on the business of rapid cell separation and pathogen diagnostics.
Shlomi Raz
Founder & Chief Executive Officer of Eleusis
Follow Shlomi Raz:
About Eleusis: Clinical stage company established to unlock the therapeutic potential of psychedelics through mitigating and managing psychoactivity
Bryan Feinberg
CEO/Founder of Lumatrack Technologies Inc
Bryan Feinberg brings nearly two decades of serial technology & media focus to the equation. With strong ties and an extensive network, Bryan’s added value is measured in his hands on approach to deal positioning, strategic modeling, market analysis & enabling technologies in any data transaction. With over 15 years of Venture Investing in both the private and public markets, Bryan is an expert on how to best position and develop IP. Bryan is a self proclaimed Startup Junkie and at the Matrix of opportunities that flow through the company. Over the past 10 years, Bryan completed over $ 150M in transactional business and was recently part of the team that led a $ 13M Private Placement and public listing for INVIVO Therapeutics (OTC: NVIV). Series 7, 63 , 79 Licensed.
Follow Bryan Feinberg:
About Lumatrack Technologies Inc: Lumatrack Technologies focuses on research and distribution.
Michael Demurjian
Manager, Founder, Chairman & CEO of Aspargo Laboratories
Michael Demurjian is a Manager, Founder, Chairman & CEO of Aspargo Laboratories. He is a successful biotech entrepreneur who has founded and successfully built several technology companies; co-founder of Tyme Inc. (Nasdaq: TYME) a clinical-stage biotechnology company developing metabolic-based cancer therapeutics.
Follow Michael Demurjian:
About Aspargo Laboratories: Aspargo Laboratories commercialize the rights of an oral suspension spray formulation of erectile dysfunction medication Sildenafil citrate.
Agon Avdimetaj
Co Founder, CTO of Vianova Health
Agon is a creative thinker, technology enthusiast, and entrepreneur with over 9 years of experience in companies that are specialized in the field of technology. He has led several tech projects with his own team and partners. His field of interest is Healthcare Technology. Agon is globally connected with several startups that he has transformed into great companies/organizations and they are now considered major key players of technology in different regions, such as North-America, Europe, and Australia.
Follow Agon Avdimetaj:
About Vianova Health: Vianova Health is reinventing home care. We personalize the technology and daily engagement to remotely care for patients
Ke Cheng
Founder & CEO of HistoWiz
Ke is a cancer researcher with expertise in mouse histopathology. She received her PhD in the laboratory of Pier Paolo Pandolfi at Harvard Medical School and led a team of investigators to publish papers in journals including Nature and Blood. She was a Teaching Fellow at Harvard University, a NCCR Molecular Oncology postdoctoral fellow in the laboratory of Douglas Hanahan at ISREC, and a scientist at a cancer diagnostic company (CGIX). Ke enjoys entrepreneurship and is actively involved in the NYC Bioscience community.
Follow Ke Cheng:
About HistoWiz, SUNY Downstate Medical Center: HistoWiz provides automated histopathology for biomedical researchers.
Paul Bakoyiannis
Co-Founder & CTO of Cylera
Paul Bakoyiannis is CTO at Cylera.
Follow Paul Bakoyiannis:
About Cylera: Cylera is a healthcare IoT cybersecurity and intelligence company used to protect healthcare organizations.
Timur Ozekcin
Co-Founder & CEO of Cylera
Timur Ozekcin is Co-Founder & CEO of Cylera.
Follow Timur Ozekcin:
About Cylera: Cylera is a healthcare IoT cybersecurity and intelligence company used to protect healthcare organizations.
Jason Ki
Co-Founder & Chief Technical Officer of Veripad
Jason Ki is the Graduate Researcher of The City College of New York.
Follow Jason Ki:
About The City College of New York, Veripad: Veripad is a health IT company with a portable and affordable device to authenticate medication.
Y-Lan Nguyen
Co-Founder & Chief Marketin Officer of Veripad
Y-Lan Nguyen is the Intern in the MS Global Customer & Market Insights Team of Biogen.
Follow Y-Lan Nguyen:
About Biogen Idec, Veripad: Veripad is a health IT company with a portable and affordable device to authenticate medication.
Da Wi Shin
Co-Founder & President of Veripad
As Co-founder and Chief Operating Officer, Da Wi Shin manages internal operations, financial matters, and legal concerns. Da Wi personally became invested in the problem of counterfeit medication on his medical mission trip to Peru. When patients questioned the quality and effectiveness of antibiotics his team was providing for free, Da Wi felt the reality of the situation and the dire need for a working solution. Da Wi graduated from the Macaulay Honors College at the City College of New York (CUNY) with a degree in Biomedical Engineering. He hopes to be at the forefront of affordable medical technology for patients in developing countries.
Follow Da Wi Shin:
About Veripad: Veripad is a health IT company with a portable and affordable device to authenticate medication.
Vladimir Ornstein
Co-Founder of MD Lingo
Vlad is currently a fourth year medical student at Jefferson Medical College, originally from Brooklyn, NY. In his spare time he enjoys watching Seinfeld, playing basketball, and trying new food.
Follow Vladimir Ornstein:
About MD Lingo: At MD Lingo, we translate recent articles from high-impact medical journals into a language and tone that patients understand
Olivier Elemento
Co-Founder of Volastra Therapeutics
Olivier Elemento is Co-Founder of Volastra and the Director of the Englander Institute for Precision Medicine at Weill Cornell Medicine.
Follow Olivier Elemento:
About Cornell University, OneThree Biotech, Volastra Therapeutics, Weill Cornell Medicine: Volastra Therapeutics is a biotechnology company developing novel therapies for the treatment of metastatic cancers.
Tim Growney
CTO & Co-Founder of Medinas Health
Tim Growney is the CTO and co-founder of Medinas Health.
Follow Tim Growney:
About Medinas Health: Medinas Health is a pre-owned medical equipment marketplace that helps to manage sales process while saving time and money.
Robert Shorr
Co-Founder & CSO of Rafael Pharmaceuticals
Robert Shorr is the Chief Executive Officer at Cornerstone Pharmaceuticals.
Follow Robert Shorr:
About Altira Group, Enzon Pharmaceuticals, Rafael Pharmaceuticals, Rafael Pharmaceuticals, SmithKline and French, United Therapeutics: Rafael Pharmaceuticals is clinical-stage, metabolic oncology therapeutics company.
Katelyn Gleason
CEO & Founder of Eligible
Katelyn Gleason is the CEO & Founder of Eligible, the leading billing infrastructure company for healthcare in the U.S.
Follow Katelyn Gleason:
About Eligible: Eligible’s powerful APIs are the easiest way to add insurance billing experiences into web and mobile applications.
Ruola Ning
Founder of Koning
Ruola Ning is the Founder of Koning.
Follow Ruola Ning:
About Koning: 3D Breast CT, Breast Cancer detection, Breast cancer diagnostics
Jon Bricken
Founder of OnSite Waste Technologies
Mr. Bricken is the inventor of an on-site portable technology for small quantity generators for the conversion of medical waste into solid waste and is named on U.S. and foreign patents.
Follow Jon Bricken:
About OnSite Waste Technologies: OnSite Waste Technologies reduces the cost, risk, and environmental impact of medical waste processing and disposal.
Peter Bechtel
Founder/CEO of WellTrackONE
Peter has been in Healthcare and Healthcare IT for 26 years. His extensive background has allowed him to create innovative products and services for the healthcare industry. He is a former Air Force Officer and is an experienced pilot and loves to fly his Piper Lance. He also plays lacrosse, lead guitar (blues) and fly fishes in Pennsylvania waters. Peter graduated from the United States Air Force Academy and served in the US Air Force (C-130E Hercules) prior to becoming an entrepreneur.
Follow Peter Bechtel:
About WellTrackONE: WellTrackONE provides patient health and wellness programs to healthcare providers and organizations.
Flavio Lobato
Co-Founder of eLum Technologies
Flavio Lobato is Founder and Managing Partner of Ikove Capital Holdings where he builds disruptive technology companies in partnership with leading research institutions via Ikove Startup Nursery – from which Cognovi Labs is a 2016 graduate. In addition to Cognovi, Flavio is Chairman of Nikola Labs, Circular Wave Drive and ParaGen Technologies. With more than 20 years in financial markets and alternative investments, Flavio is a financial and business development expert who has managed assets for high net worth families and successfully raised several billions in assets for leading global institutions. Through the Lobato Advisory Group, Flavio guides growth companies’ CEOs in developing robust businesses with high-performance financial and funding strategies. He is a student Advisor to the Harvard Innovation Lab (I-Lab) and FinTech Sector Lead for the Harvard Business School Angels of NYC. Flavio also serves on the Board of Directors for Mission Elephant, a non-profit trying to save the African elephant. Flavio received his MBA from Harvard Business School and his BA, International Finance and Marketing from the University of Miami.
Follow Flavio Lobato:
About Circular Wave Drive, Cognovi Labs, eLum Technologies, Harvard Business School Club of Greater New York, Ikove Capital Partners, ParaGen Technologies, SolitonReach: ELum Technologies is an early-stage medical device company focused on disruptive technologies to address endovascular diseases.
Owen Song
Founder and CEO of Olive Union
Follow Owen Song:
About Olive Union: Olive Union is a smart-hearing aid that prevents further hearing loss through digital therapeutics for tinnitus and overall hearing health.
David Fischell
Founder of Ablative Solutions
David Fischell is a serial entrepreneur who has founded nine biomedical device companies in the last fifteen years, including Angel Medical Systems. He is also a Director of eight biomedical technology companies (including five of those he founded) and was the primary designer of the BX Velocity™ and Cypher™ coronary stents for Cordis, a Johnson & Johnson Company. David is chairman of the Cornell University Biomedical Engineering Advisory Board, and a Fellow of the American Institute for Medical and Biological Engineering. Other companies founded by David include Neuralieve, Inc (2002) a developer of transcranial magnetic stimulation systems for migraine headaches; and NeuroPace, Inc. (1997) a developer of implantable brain pacemakers to treat epilepsy. After earning his Ph.D. in Applied Physics from Cornell University, David joined Bell Laboratories in 1979 where, for 11 years, he performed and directed a wide range of research and development projects. He left Bell Labs in 1991 to work full-time on medical devices. He currently holds 85 issued U.S. patents and has published numerous papers in the fields of telecommunications, cardiology, radiobiology, and radiation dosimetry.
Follow David Fischell:
About Ablative Solutions: Ablative Solutions is a medical device firm that offers an alternative to surgical renal denervation for treating hypertension.
Ravi Sachidanandam
Co-Founder of Girihlet
Ravi Sachidanandam is currently working on methods of analyzing high-dimensional sequencing data from the immune system to infer states of health. He trained as a physicist before making the jump to genomics. He has worked on a wide range of topics, including algorithms and tools in RNAi, mRNA splicing and bioinformatics. He has also developed more accurate methods of sequencing small RNAs, mitochondrial genomes and the TCR repertoire. Most of the work has been carried out in academic settings, and the IP from this work is the foundation of several patents which led to the founding of Girihlet Inc.
Follow Ravi Sachidanandam:
About Girihlet: Girihlet is a provider of rapid and accurate deep sequencing services with a unique focus on developing novel technologies.
Arthur Altschul Jr.
Co-Founder & Chairman of the Board of Kolltan Pharmaceuticals
Arthur G. Altschul, Jr., is the co-Founder of Kolltan and Chairman of Kolltan’s Board of Directors. Mr. Altschul has worked in money management, investment banking and as a member of senior management of a publicly-traded health care concern. He is a founder of Diaz & Altschul Capital Management, LLC, a private investment advisory firm. Between 1985 and 1991, Mr. Altschul worked, variously, at Goldman, Sachs & Co., The Maximus Fund, LP and Morgan Stanley & Co. From its founding in 1992 through 1996, Mr. Altschul worked at SUGEN, Inc., a biopharmaceutical company focused on cancer drug development, which is now owned by Pfizer, Inc. Mr. Altschul serves on the board of directors of General American Investors, Inc. (NYSE: GAM), a publicly-traded closed-end investment company with over $1 billion in gross assets and Medicis Pharmaceutical Corporation (NYSE: MRX), the leading independent specialty pharmaceutical company in the United States focusing primarily on the treatment of dermatological and aesthetic conditions. Mr. Altschul is a director of The Overbrook Foundation, a trustee of The Neurosciences Research Foundation, and a director of the Child Mind Institute. Mr. Altschul received his B.Sc. in Computer Science from Columbia University.
Follow Arthur Altschul Jr.:
About Diaz & Altschul Capital Management, Kolltan Pharmaceuticals, The Child Mind Institute, The Overbrook Foundation: Kolltan Pharmaceuticals develops new-generation monoclonal antibody oncology therapeutics.
Cuong Do
Founder & Chairman of M6P Therapeutics
Follow Cuong Do:
About BioVie, M6P Therapeutics: M6P Therapeutics develops biotechnology advances for lysosomal storage diseases.
Imran Babar
Co-Founder & Chief Business Officer of Tiburio Therapeutics
Follow Imran Babar:
About Cydan, Rare Genomics Institute, Tiburio Therapeutics: Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.
Greg Billing
Co-Founder & EVP of Field Operations of National Medtrans Network
Follow Greg Billing:
About National Medtrans Network: National MedTrans is a single source Non-Emergency Medical Transportation (NEMT) benefit management company.
Greg Kowalczyk
President & Founder of Additive Orthopaedics
Greg Kowalczyk has been involved in orthopaedic product development, marketing, business development and sales for over 20 years for companies such as Aircast, Stryker, Integra, the Prodigy Group, and MTF. Most recently, he functioned as the Vice President of Marketing and Interim CEO for Nextremity Solutions. He also founded co-founded Proception Medical, an orthopaedic medical device incubatory company. He holds a BS in Mechanical Engineering from Lehigh University and a MS in Biomedical Engineering from NJIT.
Follow Greg Kowalczyk:
About Additive Orthopaedics: Additive Orthopaedics offers innovative orthopaedic implants leveraging the power of 3D printing technology.
Co-Founder & Chief Medical Affairs Officer of Matrix Medical Network
Dr. Marcia Naveh co-founded Matrix Medical Network in 2001 in New York City, starting as a practice focused on the care of residents in nursing facilities. Today, Dr. Naveh is Chief Medical Affairs Officer and has a hand in all clinical programs and services, including the continual review and ongoing quality implementation of the company’s assessment program, coordinating with collaborating physicians throughout the country, and providing clinical leadership for new programs. She oversees clinical training, provides mentoring, and works closely with health plans and physicians in the Matrix client community. Dr. Naveh holds Bachelor of Science, cum laude, and Master of Science degrees from Tulane University. She received her MD at Albert Einstein College of Medicine, where she also completed her internal medicine residency.
Follow Marcia Naveh:
About Matrix Medical Network: Matrix Medical Network is a Health Care company.
